Real World Outcomes of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program with Commercial Lifileucel.
Authors: Amrita Desai, Cristian D Valenzuela, Matthew Blackburn et al.
Publication: Transplantation and Cellular Therapy
Published: Feb 1, 2026
Source: Crossref